Renal colic. Calculus of kidney and ureter
Conditions
Interventions
Intervention 1: In Group A, patients receive a dose of 0.6mg / kg intravenous ketamine.Pain severity base on NRS and complication such as hypertention,Tachycardia ,nausea ,dizziness,agitation , will
Treatment - Drugs
In Group A, patients receive a dose of 0.6mg / kg intravenous ketamine.Pain severity base on NRS and complication such as hypertention,Tachycardia ,nausea ,dizziness,agitation , will be recorded at 5
In Group B, patients receive a dose of 30mg intravenous ketorolac.Pain severity base on NRS and complication such as hypertention,Tachycardia ,nausea ,dizziness,agitation , will be recorded at 5th, 1
Sponsors
Tehran University of Medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: all patient with high clinical suspicious of renal colic; all patient who come with pain and have clinical or lab data of renal colic. Exclusion criteria: age < 18 years; unwilling to study participation; past history of allergy to ketorolac or ketamine; Pregnancy or probable pregnancy; Breast feeding; history of analgesic drug consumption < 4 hours ago; liver; renal or heart failure patients; decrease level of consciousness; mental disability;fibromyalgia; Vascular lesions and brain lesions; History of opium addiction; Psychosis; Refusal of the patients from the participation;Head and eyes trauma
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pain of kidney stones. Timepoint: 0 , 5 , 15 , 30 , 60 , 120 min. Method of measurement: Numeric Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypertention. Timepoint: 5, 15,30,60,120 min after intervention. Method of measurement: Using a questionnaire , Measurement of vital signs.;Tachycardia. Timepoint: 5, 15,30,60,120 min after intervention. Method of measurement: Using a questionnaire, measurement of vital signs.;Nausea. Timepoint: 5, 15,30,60,120 min after intervention. Method of measurement: Using a questionnaire.;Dizziness. Timepoint: 5, 15,30,60,120 min after intervention. Method of measurement: Using a questionnaire.;Agitation. Timepoint: 5, 15,30,60,120 min after intervention. Method of measurement: Using a questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mozhgan Farmahini Farahani
Tehran University of Medical sciences
Outcome results
None listed